Related Experiment Video
Updated: Sep 23, 2025
09:34
Uptake of New Lipid-coated Nanoparticles Containing Falcarindiol by Human Mesenchymal Stem Cells
Published on: February 9, 2019
9.1K
Bilayer Forming Phospholipids as Targets for Cancer Therapy
Celine Stoica1, Adilson Kleber Ferreira2,3, Kayleigh Hannan1
1Department of Human Health and Nutritional Science, College of Biological Sciences, University of Guelph, 50 Stone Road East, Guelph, ON N1G 2W1, Canada.
International Journal of Molecular Sciences
|May 14, 2022
Summary
Phospholipid metabolism, particularly phosphatidylcholine and phosphatidylethanolamine, is altered in cancer. Profiling these changes may aid in cancer diagnosis and developing new therapies.
Area of Science:
- Biochemistry
- Molecular Biology
- Oncology
Background:
- Phospholipids, including phosphatidylcholine and phosphatidylethanolamine, are vital for cell membrane structure.
- The Kennedy pathway governs the de novo biosynthesis of these essential phospholipids.
- Dysregulation of the Kennedy pathway is implicated in various human diseases, notably cancer.
Purpose of the Study:
- To review changes in phospholipid metabolism during oncogenic transformation.
- To explore the utility of phospholipid profiling in distinguishing cancer from healthy tissues.
- To discuss the potential of phospholipids as diagnostic biomarkers and therapeutic targets in cancer.
Main Methods:
- Literature review focusing on phospholipid metabolism and cancer.
- Analysis of studies examining phospholipid profiles in cancer tissues.
- Synthesis of research on the Kennedy pathway and its role in oncogenesis.
Main Results:
- Altered membrane content, metabolite levels, and fatty acid profiles of phospholipids are hallmarks of cancer.
- Phospholipid profiling shows promise in differentiating between cancerous and healthy tissues.
- Specific cancers like colorectal, breast, and non-small cell lung cancer exhibit distinct phospholipid alterations.
Conclusions:
- Changes in phospholipid metabolism are critical indicators of cancer development and progression.
- Phospholipid profiling offers potential for early cancer detection and diagnosis.
- Targeting phospholipid metabolism presents a promising avenue for novel anticancer therapies.
More Related Videos
07:32Preparation and Characterization of Individual and Multi-drug Loaded Physically Entrapped Polymeric Micelles
Published on: August 28, 2015
11.4K
14:20Polymalic Acid-based Nano Biopolymers for Targeting of Multiple Tumor Markers: An Opportunity for Personalized Medicine?
Published on: June 13, 2014
16.8K
Related Concept Videos
02:57Targeted Cancer Therapies
7.9K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.9K
01:35Asymmetric Lipid Bilayer
8.0K
Biological membranes show uneven distribution of different types of lipids in the inner and outer layers, resulting in transverse asymmetric membranes. The treatment of the erythrocyte membrane with the enzyme phospholipase confirmed the asymmetric nature of the lipid bilayer. The enzyme hydrolyzes lipids into fatty acids and hydrophilic groups. The phospholipase acts only on the outer layer of the membrane, while the inner layer remains intact. The phospholipase treatment resulted in 80%...
8.0K
02:50Combination Therapies and Personalized Medicine
5.1K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
5.1K
01:26Targets for Drug Action: Overview
7.6K
Drugs target macromolecules to modify ongoing cellular processes. Primary drug targets include receptors, ion channels, transporters, and enzymes.
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
7.6K
01:27Transducer Mechanism: Enzyme-Linked Receptors
2.9K
Enzyme-linked receptors are cell-surface receptors acting as an enzyme or associating with an enzyme intracellularly. They make excellent drug targets. Drugs can bind to the extracellular ligand-binding domain or directly affect their enzymatic domain and alter their activity.
Major types that are helpful drug targets include:
Major types that are helpful drug targets include:
2.9K
02:38Mitogens and the Cell Cycle
7.0K
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
7.0K